Multiplicity and flexibility in clinical trials

Pharmaceutical Statistics

Volumn 6, Issue 3, 2007, Pages 205-216

  Brannath, Werner ^a   Koenig, Franz ^a   Bauer, Peter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Adaptive design; Hierarchical test; Multiple comparison; Multiple type I error rate; Step down Dunnett test; Treatment selection

Indexed keywords

ENIPORIDE; PLACEBO;

ACUTE HEART INFARCTION; ANALYTICAL ERROR; CLINICAL TRIAL; DATA ANALYSIS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; DRUG SYNTHESIS; HUMAN; HYPOTHESIS; METHODOLOGY; NORMAL DISTRIBUTION; NULL HYPOTHESIS; OUTCOMES RESEARCH; PROBABILITY; REVIEW; SAMPLE SIZE; SCORING SYSTEM; ST SEGMENT ELEVATION; STANDARDIZATION; STATISTICAL ANALYSIS; TREATMENT PLANNING;

BIAS (EPIDEMIOLOGY); CLINICAL TRIALS; DATA INTERPRETATION, STATISTICAL; DRUG DESIGN; ENDPOINT DETERMINATION; HUMANS; MODELS, STATISTICAL; RESEARCH DESIGN; SAMPLE SIZE;

EID: 34648823145     PISSN: 15391604     EISSN: 15391612     Source Type: Journal    
DOI: 10.1002/pst.302     Document Type: Review

References (32)

1. Gallo P, Krams M. PhRMA working group on adaptive designs: introduction to the full white paper. Drug Information Journal 2006; 40:421-423.
2. Bauer P, Kieser M. Combining different phases in the development of medical treatments within a single trial. Statistics in Medicine 1999; 18: 1833-1848.
3. Kieser M, Bauer P, Lehmacher W. Inference on multiple endpoints in clinical trials with adaptive interim analyses. Biometrical Journal 1999; 41: 261-277.
4. Hommel G. Adaptive modifications of hypotheses after an interim analysis. Biometrical Journal 2001; 43:581-589.
5. Posch M, König F, Branson M, Brannath W, Dunger-Baldauf C, Bauer P. Adaptive treatment selection. Statistics in Medicine 2005; 24:3697-3714.
6. Kelly PJ, Stallard N, Todd S. An adaptive group sequential design for phase II/III clinical trials that involve treatment selection. Journal of Biopharmaceutical Statistics 2005; 15:641-658.
7. Todd S, Stallard N. A new clinical trial design combining phases II and III: sequential designs with treatment selection and a change of endpoint. Drug Information Journal 2005; 39:109-118.
8. Bretz F, Schmidli H, Koenig F, Racine A, Maurer W. Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: general concepts. Biometrical Journal 2006; 48:623-634.
9. Schmidli H, Bretz F, Racine A, Maurer W. Confirmatory seamless phase II/ III clinical trials with hypotheses selection at interim: applications and practical considerations. Biometrical Journal 2006; 48:635-643.
10. Koenig F, Bauer P, Brannath W. An adaptive hierarchical test procedure for selecting safe and efficient treatments. Biometrical Journal 2006; 48:663-678.
11. Jennison C, Turnbull BW. Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: opportunities and limitations. Biometrical Journal 2006; 48:650-655.
12. Koenig F, Brannath W, Bretz F, Posch M. Adaptive Dunnett tests for treatment selection. 2006, submitted.
13. Hung HMJ, O'Neill RT, Wang SJ, Lawrence J. A regulatory view on adaptive/ flexible clinical trial design. Biometrical Journal 2006; 48:565-573.
14. Koch A. Confirmatory clinical trials with an adaptive design. Biometrical Journal 2006; 48:574-585.
15. CMP. Reflection paper on methodological issues in confirmatory clinical trials with flexible design and analysis plan (draft). The European Agency for the Evaluation of Medicinal Products, London, 2006.
16. Zuber E, Brannath W, Branson M, Bretz F, Gallo P, Posch M, Racine-Poon A. Phase II/III seamless adaptive designs with bayesian decision tools for an efficient development of a targeted therapy in oncology. Technical Report, TM 2006-05, Department of Statistics and Decision Support Systems, University of Vienna.
17. + exchange inhibitor Eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Journal of the American College of Cardiology 2001; 38:1644-1651.
18. Dragalin V. Adaptive designs: terminology and classification. Drug Information Journal 2006; 40:425-435.
19. Müller HH, Schäfer H. Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and of classical group sequential approaches. Biometrics 2001; 57:886-891.
20. Müller HH, Schäfer H. A general statistical principle for changing a design any time during the course of a trial. Statistics in Medicine 2004; 23:2497-2508.
21. Mehta CR, Bauer P, Posch M, Brannath W. Repeated confidence intervals for adaptive group sequential trials. 2006, submitted.
22. Liu Q, Proschan MA, Pledger GW. A unified theory of two-stage adaptive designs. Journal of the American Statistical Association 2002; 97: 1034-1041.
23. Proschan MA, Hunsberger SA. Designed extension of studies based on conditional power. Biometrics 1995; 51:1315-1324.
24. Bauer P. Multistage testing with adaptive designs (with discussion). Biometrie und Informatik in Medizin und Biologie 1989; 20:130-148.
25. Bauer P, Köhne K. Evaluation of experiments with adaptive interim analyses. Biometrics 1994; 50: 1029-1041.
26. Posch M, Bauer P. Adaptive two stage designs and the conditional error function. Biometrical Journal 1999; 41:689-696.
27. Wassmer G. Statistische Testverfahren für gruppensequentielle und adaptive Pläne in klinischen Studien. Verlag Alexander Mönch: Köln, Germany, 1999.
28. Posch M, Timmesfeld N, König F, Müller HH. Conditional rejection probabilities of Student's t-test and design adaptations. Biometrical Journal 2004; 46:389-403.
29. Timmesfeld N, Schäfer H, Müller HH. Increasing the sample size during clinical trials with t-distributed test statistics without inflating the type I error rate. Statistics in Medicine 2006; 26:2449-2464.
30. Posch M, Bauer P, Brannath W. Issues in designing flexible trials. Statistics in Medicine 2003; 23: 953-969.
31. Bauer P. Multiple testing in clinical trials. Statistics in Medicine 1991; 10:871-889.
32. Chen YHJ, DeMets DL, Lan KKG. Increasing the sample size when the unblinded interim result is promising. Statistics in Medicine 2004; 23: 1023-1038.